The Clinical Study of Acute Pancreatitis Treated by TongFuSan
NCT ID: NCT02204189
Last Updated: 2014-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
100 participants
INTERVENTIONAL
2014-03-31
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Traditional Chinese Medicine on GI Function Recovery and Nutrition Support in SAP
NCT00508729
Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms
NCT01844050
Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis
NCT04990336
Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis
NCT00506337
Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis
NCT06933238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Patients will be divided into two groups as random number table: control group(A) and experimental group(B).
* Group A will be given Mosapride po,and group B will be given TongFusan except for basic treatments of AP.
* Same investigator will write the case report form.
* Investigator will collect the patients' blood in three points: on admission, the third day and the seventh day.
* Otherwise, we need write down patients' clinical manifestation,Traditional Chinese Medicine differentiation, the result of clinical tests.
* When the patient discharge, we will write down the treatment measures, therapeutic effect, length of stay and the costs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TongFuSan
TongFuSan 1g per time, change every day, the duration is seven days
TongFuSan
TongFuSan 1g
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TongFuSan
TongFuSan 1g
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* cancer in late time
* patient near death
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Friendship Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
miaobin
associate chief physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bin Miao, PHD
Role: STUDY_CHAIR
Beijing Friendship Hospital
Hong Wang, Graduate
Role: STUDY_DIRECTOR
Beijing Friendship Hospital
Shuwen Zhang, bachelor
Role: STUDY_DIRECTOR
Beijing Friendship Hospital
Chao Wang, PHD
Role: PRINCIPAL_INVESTIGATOR
Beijing Friendship Hospital
Yanli Su, PHD
Role: PRINCIPAL_INVESTIGATOR
Beijing Friendship Hospital
Shirong Li, graduate
Role: PRINCIPAL_INVESTIGATOR
Beijing Friendship Hospital
Fengwu Li, graduate
Role: PRINCIPAL_INVESTIGATOR
Beijing Friendship Hospital
Dinghua Xu, graduate
Role: PRINCIPAL_INVESTIGATOR
Beijing Friendship Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Friendship Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Hong You, PHD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hong You, PHD
Role: primary
Wanzhen Xu, PHD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
z141100002114004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.